SCHEMBL3402397

SCHEMBL3402397

OB(O)c1ccc(OC(F)I)nc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL248140 0.86 DAO (0.37)
SCHEMBL30525517 0.86 DAO (0.37)
SCHEMBL561514 0.79 ALDH1A1 (0.45)
SCHEMBL29636288 0.79 ALDH1A1 (0.45)
SCHEMBL17646787 0.73 LPL (0.32)
SCHEMBL29643889 0.72 ENPP2 (0.48)
SCHEMBL4942 0.72 ENPP2 (0.48)
SCHEMBL29838067 0.71 MGLL (0.39)
SCHEMBL3693742 0.71 MGLL (0.39)
Hydrochloric Acid SCHEMBL1870385 0.71 ENPP2 (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012003283-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE AS INHIBITORS OF PI3K ACTIVITY AMGEN INC. (US) 2012-01-05 WO disclosed